Xiaoping Li
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Xiaoping Li has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
- Chunyu Zeng
Department of Cardiology, Daping Hospital, Third Military Medical University, Chongqing, China
1 shared publication Conghui Li
1 shared publicationDingqin Cai
1 shared publication- Gengze Wu
Department of Cardiology, Daping Hospital, The Third Military Medical University (Army Medical University), Chongqing, People’s Republic of China
1 shared publication Han Zhan
1 shared publication- Limin Liu1 shared publication
Latest Publications
- Open Access
- 1 April 2026
- Published by AME Publishing Company in Translational Cancer Research
- Vol. 15 (4) , 304
Tirzepatide attenuates doxorubicin-induced cardiotoxicity via mitochondrial function improvement
Background: Doxorubicin (DOX) can induce significant cardiotoxicity and compromise the safety of its clinical application. This study explored the cardioprotective potential of tirzepatide against DOX-induced cardiotoxicity. Methods: In this study, we employed both in vitro and in vivo DOX injury models to systematically assess cardiac function and myocardial tissue structure through echocardiography and histopathological analysis. Additionally, we examined mitochondrial ultrastructure using transmission electron microscopy (TEM) and evaluated mitochondrial membrane potential (MMP). Results: Our findings revealed that tirzepatide administration significantly enhanced cardiac systolic performance and reduced myocardial damage. Notably, tirzepatide effectively preserved mitochondrial function by maintaining cristae integrity and restoring MMP. Conclusions: These results demonstrate that tirzepatide confers protection against DOX-induced cardiotoxicity primarily through the amelioration of mitochondrial dysfunction.
- 1 April 2026
- Published by AME Publishing Company in Translational Cancer Research
- Vol. 15 (4) , 304
Open AccessTirzepatide attenuates doxorubicin-induced cardiotoxicity via mitochondrial function improvement
Background: Doxorubicin (DOX) can induce significant cardiotoxicity and compromise the safety of its clinical application. This study explored the cardioprotective potential of tirzepatide against DOX-induced cardiotoxicity. Methods: In this study, we employed both in vitro and in vivo DOX injury models to systematically assess cardiac function and myocardial tissue structure through echocardiography and histopathological analysis. Additionally, we examined mitochondrial ultrastructure using transmission electron microscopy (TEM) and evaluated mitochondrial membrane potential (MMP). Results: Our findings revealed that tirzepatide administration significantly enhanced cardiac systolic performance and reduced myocardial damage. Notably, tirzepatide effectively preserved mitochondrial function by maintaining cristae integrity and restoring MMP. Conclusions: These results demonstrate that tirzepatide confers protection against DOX-induced cardiotoxicity primarily through the amelioration of mitochondrial dysfunction.
- 17 November 2023
- Published by Springer Nature in Interdisciplinary Sciences: Computational Life Sciences
- Vol. 16 (1) , 104-122
Comprehensive scRNA-seq Model Reveals Artery Endothelial Cell Heterogeneity and Metabolic Preference in Human Vascular Disease
Vascular disease is one of the major causes of death worldwide. Endothelial cells are important components of the vascular structure. A better understanding of the endothelial cell changes in the development of vascular disease may provide new targets for clinical treatment strategies. Single-cell RNA sequencing can serve as a powerful tool to explore transcription patterns, as well as cell type identity. Our current study is based on comprehensive scRNA-seq data of several types of human vascular disease datasets with deep-learning-based algorithm. A gene set scoring system, created based on cell clustering, may help to identify the relative stage of the development of vascular disease. Metabolic preference patterns were estimated using a graphic neural network model. Overall, our study may provide potential treatment targets for retaining normal endothelial function under pathological situations. Graphical abstract
- 17 November 2023
- Published by Springer Nature in Interdisciplinary Sciences: Computational Life Sciences
- Vol. 16 (1) , 104-122
Comprehensive scRNA-seq Model Reveals Artery Endothelial Cell Heterogeneity and Metabolic Preference in Human Vascular Disease
Vascular disease is one of the major causes of death worldwide. Endothelial cells are important components of the vascular structure. A better understanding of the endothelial cell changes in the development of vascular disease may provide new targets for clinical treatment strategies. Single-cell RNA sequencing can serve as a powerful tool to explore transcription patterns, as well as cell type identity. Our current study is based on comprehensive scRNA-seq data of several types of human vascular disease datasets with deep-learning-based algorithm. A gene set scoring system, created based on cell clustering, may help to identify the relative stage of the development of vascular disease. Metabolic preference patterns were estimated using a graphic neural network model. Overall, our study may provide potential treatment targets for retaining normal endothelial function under pathological situations. Graphical abstract